skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Obesity is not associated with contrast nephropathy

Original Research

(1880) Views  (443) Full article downloads

Authors: Navin Jaipaul, Rendell Manalo, Seyed-Ali Sadjadi, et al

Published Date May 2010 Volume 2010:6 Pages 213 - 217
DOI: http://dx.doi.org/10.2147/TCRM.S10198

Navin Jaipaul1, Rendell Manalo2, Seyed-Ali Sadjadi1, James McMillan1

1Section of Nephrology, VA Loma Linda Healthcare System, 2Department of Medicine, Loma Linda University School of Medicine, Loma Linda, CA, USA

Background: Exposure to radiocontrast media may result in acute kidney injury (AKI) or traditionally defined contrast nephropathy (CN), both of which may lead to increased morbidity and mortality. The pathogenesis of both these variants of contrast-induced nephropathy (CIN) may involve inflammatory mediators that lead to renal impairment. A link between obesity and inflammation has been clearly established, but whether obesity is independently associated with CIN is unknown.

Objective: To determine whether obesity, when stratified by body mass index (BMI), is a risk factor for CIN in a large and hemodynamically stable population of hospitalized United States veterans.

Design: Retrospective chart review.

Measurements: Presence or absence of AKI or CN after intravenous radiocontrast administration and comparison of patient characteristics between those with versus without AKI or CN.

Results: The overall prevalence of AKI and CN was 16.1% and 12.6%, respectively. Patients with AKI or CN were comparable to those without radiocontrast injury, except that affected patients tended to be older and diabetic. When stratified by BMI, obesity was not found to be associated with the development of AKI or CN after exposure to radiocontrast.

Conclusion: Obesity does not appear to be an independent risk factor for AKI or CN after exposure to radiocontrast.

Keywords: obesity, contrast nephropathy, kidney injury






 

Other articles by Dr Navin Jaipaul



Readers of this article also read:

Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of male wistar albino rats
Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision
Maximum opening of the mouth by mouth prop during dental procedures increases the risk of upper airway constriction
Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats
Update on the diagnosis and management of acute kidney injury
Role of aliskiren in blood pressure control and renoprotection
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials
Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis